Stemvax: Innovest Global Launches Biotech Division
With the acquisition of a 20% interest in StemVax Therapeutics, who is currently developing a cancer vaccine therapy
Read full article »
StemVax is a biotechnology company that develops and commercializes stem cell-based immunotherapies for the treatment of brain tumor.
Read more